Bravecto MSD 4.5-10Kg

Bravecto 250 mg Chewable Tablet for Small Dogs (4.5–10 kg)

Product Overview
Bravecto is a veterinary prescription (POM-V) chewable tablet for dogs weighing between 4.5 kg and 10 kg . Manufactured by MSD Animal Health (Merck Animal Health), it provides long-lasting protection against fleas and ticks with a single dose .

Key Specifications

Key Benefits

Indications for Use

Bravecto is indicated for the treatment and prevention of :

Additional Indications:

• Can be used as part of a treatment strategy for Flea Allergy Dermatitis (FAD) 

• Reduces the risk of Babesia canis (babesiosis) transmission by ticks 

• Reduces the risk of Dipylidium caninum (tapeworm) transmission by fleas 

Dosage and Administration

Administration Instructions:

• Administer orally at or around the time of feeding 

• The chewable tablet should not be broken or divided 

• Dogs over 56 kg should receive a combination of tablets that most closely matches body weight 

Safety Information

Contraindications:

• Do not use in puppies less than 8 weeks of age or weighing less than 2 kg 

• Do not use in case of hypersensitivity to fluralaner or any excipients 

Warnings and Precautions:

• Use with caution in dogs with pre-existing epilepsy 

• Do not administer at intervals shorter than 8 weeks as safety for shorter intervals has not been tested 

• Fleas and ticks must attach to the host and commence feeding to be exposed to the active substance 

• The product should be stored in its original packaging at or below 30°C 

Adverse Reactions

Common adverse reactions observed in clinical trials (1.6% of treated dogs) were mild and transient gastrointestinal effects :

Most reported adverse reactions were self-limiting and of short duration .

Storage Instructions

• Store at or below 30°C in a cool, dry place 

• Keep in the original packaging to protect from light 

• Keep out of reach of children and uninformed persons